Micromachines,
Journal Year:
2024,
Volume and Issue:
15(8), P. 955 - 955
Published: July 26, 2024
Wearable
and
implantable
bio-MEMS
sensors
actuators
have
attracted
tremendous
attention
in
the
fields
of
health
monitoring,
disease
treatment,
human-machine
interaction,
to
name
but
a
few
[...].
Biosensors and Bioelectronics X,
Journal Year:
2024,
Volume and Issue:
19, P. 100503 - 100503
Published: May 31, 2024
The
next
generation
of
wearable
biosensors
comes
with
the
latest
advancements
in
biosensor
technology.
Soft
and
stretchable
electrode
materials
like
hydrogels
similar
functionalities
human
tissue
including
stretchability,
self-healability,
responsiveness
to
different
stimuli
have
emerged
as
most
versatile
electronics.
incorporation
conductive
nanofillers
is
found
enhance
sensitivity
electrochemical
significantly.
Microfluidic
technology
has
reduced
volume
samples
reagents
required
for
analysis,
allowing
continuous
biomedical
monitoring
from
a
drop
biofluid.
In
this
paper,
advanced
progress
platforms
that
can
noninvasively
continuously
monitor
biochemical
markers
body
fluids
diagnosis
health
management
reviewed.
Innovation
microelectronics,
modification,
fabrication
technologies,
detection
methods
are
main
focus
discussion.
particular,
hydrogel-based
sensors
microfluidic
systems
trends
discussed
detail.
Integration
miniaturized
wireless
great
promise
real-time
healthcare
point-of-care
(POC)
diagnostics
also
summarized.
Finally,
we
outline
optimized
material
design
well
key
challenges
need
be
addressed
improve
sensing
performance
(accuracy,
sensitivity,
selectivity,
stability),
portability
(miniaturized
size
light
weight),
flexibility
biosensors.
Sports
cardiology
focuses
on
athletes'
cardiovascular
health,
yet
sudden
cardiac
death
remains
a
significant
concern
despite
preventative
measures.
Prolonged
physical
activity
leads
to
notable
adaptations,
known
as
the
athlete's
heart,
which
can
resemble
certain
pathological
conditions,
complicating
accurate
diagnoses
and
potentially
leading
serious
consequences
such
unnecessary
exclusion
from
sports
or
missed
treatment
opportunities.
Wearable
devices,
including
smartwatches
smart
glasses,
have
become
prevalent
for
monitoring
health
metrics,
offering
potential
clinical
applications
cardiologists.
These
gadgets
are
capable
of
spotting
exercise-induced
arrhythmias,
uncovering
hidden
heart
problems,
crucial
information
training
recovery,
minimize
exercise-related
incidents
enhance
care.
However,
concerns
about
data
accuracy
actionable
value
obtained
persist.
A
major
challenge
lies
in
integration
artificial
intelligence
with
wearables,
research
gaps
remain
regarding
their
ability
provide
real-time,
reliable,
clinically
relevant
insights.
Combining
wearable
devices
improve
how
is
managed
used
cardiology.
Artificial
intelligence,
particularly
machine
learning,
classify,
predict,
draw
inferences
collected
by
revolutionizing
patient
usage.
Despite
intelligence's
proven
effectiveness
managing
chronic
limited
its
application
cardiology,
creates
critical
gap
that
needs
be
addressed.
This
review
examines
commercially
available
wearables
exploring
integrated
into
technology
advance
field.
World Journal of Clinical Cases,
Journal Year:
2024,
Volume and Issue:
12(1), P. 1 - 8
Published: Jan. 2, 2024
Type
2
diabetes
mellitus
(T2DM)
is
a
chronic
metabolic
disorder
characterized
by
hyperglycemia
and
insulin
resistance.
The
global
prevalence
of
T2DM
has
reached
epidemic
proportions,
affecting
approximately
463
million
adults
worldwide
in
2019.
Current
treatments
for
include
lifestyle
modifications,
oral
antidiabetic
agents,
therapy.
However,
these
therapies
may
carry
side
effects
fail
to
achieve
optimal
glycemic
control
some
patients.
Therefore,
there
growing
interest
the
role
gut
microbiota
more
gut-targeted
management
T2DM.
microbiota,
which
refers
community
microorganisms
that
inhabit
human
gut,
been
shown
play
crucial
regulation
glucose
metabolism
sensitivity.
Alterations
composition
diversity
have
observed
patients,
with
reduction
beneficial
bacteria
an
increase
pathogenic
bacteria.
This
dysbiosis
contribute
pathogenesis
disease
promoting
inflammation
impairing
barrier
function.
Several
developed
modulate
improve
One
potential
approach
use
probiotics,
are
live
confer
health
benefits
host
when
administered
adequate
amounts.
randomized
controlled
trials
demonstrated
certain
such
as
Lactobacillus
Bifidobacterium
species,
can
sensitivity
Mechanisms
production
short-chain
fatty
acids,
improvement
function,
inflammation.
Another
therapy
fecal
transplantation
(FMT),
involves
transfer
material
from
healthy
donor
recipient.
FMT
used
successfully
treatment
Biosensors,
Journal Year:
2024,
Volume and Issue:
14(3), P. 148 - 148
Published: March 18, 2024
Lactate,
once
merely
regarded
as
an
indicator
of
tissue
hypoxia
and
muscular
fatigue,
has
now
gained
prominence
a
pivotal
biomarker
across
various
medical
disciplines.
Recent
research
unveiled
its
critical
role
high-value
prognostic
marker
in
care
medicine.
The
current
practice
lactate
detection
involves
periodic
blood
sampling.
This
approach
is
invasive
confined
to
measurements
at
six-hour
intervals,
leading
resource
expenditure,
time
consumption,
patient
discomfort.
review
addresses
non-invasive
sensors
that
enable
continuous
monitoring
patients.
After
the
introduction,
it
discusses
iontophoresis
system,
followed
by
description
structural
materials
are
universally
employed
create
interface
between
integumentary
system
sensor.
Subsequently,
each
method
detailed
according
physical
principle,
outlining
advantages,
limitations,
pertinent
aspects.
study
concludes
with
discussion
conclusions,
aiming
design
intelligent
sensor
(Internet
Medical
Things
or
IoMT)
facilitate
enhance
clinical
decision-making
support